Harringtonine

For research use only. Not for therapeutic Use.

  • CAT Number: I002921
  • CAS Number: 26833-85-2
  • Molecular Formula: C28H37NO9
  • Molecular Weight: 531.60
  • Purity: ≥95%
Inquiry Now

Harringtonine(Cat No.:I002921)is a potent alkaloid derived from the plant Cephalotaxus harringtonia, known for its significant role in cancer research. It functions as an inhibitor of protein synthesis by targeting the elongation factor eEF2, thereby halting translation in cells. This mechanism makes it valuable in the study of cellular processes and as a potential chemotherapeutic agent. Harringtonine has shown activity against various cancers, including leukemia and solid tumors, and is of interest in drug development for its ability to selectively inhibit cancer cell growth while sparing normal cells.


Catalog Number I002921
CAS Number 26833-85-2
Synonyms

3-[4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate]cephalotaxine

Molecular Formula C28H37NO9
Purity ≥95%
Target Influenza Virus
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate
InChI InChI=1S/C28H37NO9/c1-26(2,32)8-9-28(33,15-22(30)35-4)25(31)38-24-21(34-3)14-27-7-5-10-29(27)11-6-17-12-19-20(37-16-36-19)13-18(17)23(24)27/h12-14,23-24,32-33H,5-11,15-16H2,1-4H3/t23-,24-,27+,28-/m1/s1
InChIKey HAVJATCHLFRDHY-KSZYUSJVSA-N
SMILES CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
Reference

<p style=/line-height:25px/>
<br>[1]. Fresno M, et al. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem. 1977 Jan;72(2):323-30.

<br>[2]. Kaur P, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.

<br>[3]. Yunmbam MK, et al. Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts. Oncol Rep. 2004 Apr;11(4):833-8.

</p>

Request a Quote